Your search returned 12 results.

Results
	1.	Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 32983983 Year: 2020 Citation: Frontiers in Oncology. 10:1475, 2020. Institution: Washington Cancer Institute Department: Associate Dean for Research Development MedStar Health Medline publication type: Journal Article Form of publication: Journal Article All authors: Elliott A, Gatalica Z, Heeke AL, Isaacs C, Khoury K, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Simon M, Swain SM, Tan AR, Xiu J DOI: https://dx.doi.org/10.3389/fonc.2020.01475 Add to cart (remove)
	2.	Pertuzumab for the treatment of breast cancer. [Review] MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 24921704 Year: 2014 Citation: Cancer Investigation. 32(8):430-8, 2014 Oct. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Review Form of publication: Journal Article All authors: Lynce F, Swain SM DOI: http://dx.doi.org/10.3109/07357907.2014.922570 Add to cart (remove)
	3.	Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway. MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 32776290 Year: 2020 Citation: Breast Cancer Research & Treatment. 184(2):265-275, 2020 Nov. Institution: Washington Cancer Institute Department: Associate Dean for Research Development MedStar Health Medline publication type: Journal Article Form of publication: Journal Article All authors: Elliott A, Heeke AL, Isaacs C, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Swain SM, Tan AR, Vidal G, Xiu J DOI: https://dx.doi.org/10.1007/s10549-020-05849-2 Add to cart (remove)
	4.	Avastin withdrawal symptoms. MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 22263961 Citation: Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb. Institution: Washington Cancer Institute Medline publication type: Editorial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Lynce F, Swain SM DOI: http://dx.doi.org/10.1517/14656566.2012.652088 Add to cart (remove)
	5.	Molecular characterization of trophoblast cell surface antigen 2 (Trop-2) positive triple-negative breast cancer (TNBC). MedStar authors: Khoury, Katia Lynce, Filipa Swain, Sandra M Year: 2019 Citation: 2019/04/30/ Department: MedStar Georgetown University Hospital Residents Form of publication: Poster Presentation All authors: Khoury K, Feldman R, Pohlmann P, Lutterman A...[Swain S, Lynce F], et al. Local accession number: C2019_354 Add to cart (remove)
	6.	SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors: Asch, Federico M Barac, Ana Lynce, Filipa Swain, Sandra M PMID: 28314836 Year: 2017 Citation: Oncologist. 22(5):518-525, 2017 May Institution: MedStar Heart & Vascular Institute Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT DOI: https://dx.doi.org/10.1634/theoncologist.2016-0412 Add to cart (remove)
	7.	Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: the OXEL study. MedStar authors: Dilawari, Asma Gallagher, Christopher Khoury, Katia Lynce, Filipa Swain, Sandra M Year: 2018 Department: MedStar Georgetown University Hospital Residents Form of publication: Conference All authors: Khoury K, Isaacs C, Gatti-Mays M, Donahue R, Schlom J, Wang H, Gallagher C, Graham D, Warren R, Dilawari A, Swain S, Pohlmann P, Lynce F. Local accession number: C2019_426 Add to cart (remove)
	8.	Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: the OXEL study. MedStar authors: Dilawari, Asma Gallagher, Christopher Khoury, Katia Lynce, Filipa Swain, Sandra M Year: 2019 Citation: 2019/04/30/ Department: MedStar Georgetown University Hospital Residents Form of publication: Poster Presentation All authors: Khoury K, Isaacs C, Gatti-Mays M, Donahue R, Schlom J, Wang H, Gallagher C, Graham D, Warren R, Dilawari A, Swain S, Pohlmann P, Lynce F. Local accession number: C2019_353 Add to cart (remove)
	9.	Cardiac function in BRCA1/2 mutation carriers with a history of breast cancer treated with anthracyclines MedStar authors: Barac, Ana Herbolsheimer, Pia M Isaacs, C Lynce, Filipa Mete, Mihriye Nunes, Raquel Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Mar 9 Department: MedStar Heart and Vascular Institute Form of publication: Poster Presentation All authors: Barac A, Lynce F, Mete M, Herbolsheimer P, Nunes R, Swain S, Warren R, Isaacs C Local accession number: 2015_49 Add to cart (remove)
	10.	Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function. MedStar authors: Asch, Federico M Barac, Ana Gallagher, Christopher Hofmeyer, Mark Lynce, Filipa Srichai, Monvadi B Swain, Sandra M PMID: 33400034 Year: 2021 Citation: Breast Cancer Research & Treatment. 2021 Jan 05 Institution: MedStar Heart & Vascular Institute Washington Cancer Institute Department: Associate Dean for Research Development MedStar Health Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch F, Barac A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Khoury K, Lynce F, Nunes R, Pohlmann PR, Smith KL, Srichai MB, Swain SM, Tan M, Warren R, Yu AF DOI: https://dx.doi.org/10.1007/s10549-020-06053-y Add to cart (remove)
	11.	Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors: Asch, Federico M Barac, Ana Herbolsheimer, Pia M Lynce, Filipa Mete, Mihriye Nunes, Raquel Shara, Nawar M Swain, Sandra M Wray, Lynette PMID: 26749359 Year: 2016 Citation: Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan. Institution: MedStar Health Research Institute MedStar Health Research Institute MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Washington Cancer Institute Washington Cancer Institute Washington Cancer Institute A Washington Cancer Instituteia Department: MedStar Heart Institute MedStar Heart Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L Add to cart (remove)
	12.	Video intervention increases participation of black breast cancer patients in therapeutic trials. MedStar authors: Gallagher, Christopher Herbolsheimer, Pia M Lee, Young Lynce, Filipa Mete, Mihriye Mohapatra, Avani Mohebtash, Mahsa Newman, Antoinette F Nunes, Raquel Omogbehin, Adedamola Ottaviano, Yvonne Randolph-Jackson, Pamela Robinson, Brandi N Swain, Sandra M Tefera, Eshetu PMID: 28944289 Year: 2017 Citation: NPJ Breast Cancer. 3:36, 2017 Institution: MedStar Franklin Square Medical Center MedStar Harbor Hospital MedStar Health Research Institute MedStar Union Memorial Hospital Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Brown R, Dilawari A, Gallagher C, Herbolsheimer P, Lee Y, Lynce F, Mete M, Mohapatra A, Mohebtash M, Newman AF, Nunes R, Omogbehin A, Ottaviano Y, Pohlmann PR, Randolph-Jackson P, Robinson BN, Swain SM, Tefera E DOI: https://dx.doi.org/10.1038/s41523-017-0039-1 Add to cart (remove)

Powered by Koha